Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 2

Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

Propedix, Inc. · NCT07245667

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 16+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 2
Target enrollment
150
US sites recruiting
2
Study start
December 30, 2024
Record last updated
November 28, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).

Being studied: 1% Tolnaftate Stick Formula A; 1% Tolnaftate Stick Formula B; 1% Tolnaftate Stick Formula C

Conditions: Tinea Pedis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Male or female, aged 16 or above
  • Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)
  • Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)
  • Signed and dated informed consent form
  • Willingness to comply with study protocol and availability for the duration of the study

Exclusion Criteria

  • Diagnosis of moccasin-type tinea pedis
  • Presence of serous exudate or pus
  • Treatment with a topical antifungal in the past 2 weeks
  • Treatment with a systemic antifungal in the past 4 weeks
  • Concurrent immunosuppressive or antimicrobial therapy
  • Liver disease
  • Pregnancy or breastfeeding
  • Use any other antifungal therapy during trial or within three months of starting the trial
  • Known hypersensitivity to any ingredients of trial agents
  • Patients with a current diagnosis of diabetes or neuropathy

Recruiting US locations

  • Kuchnir Dermatology and Dermatological Surgery

    Framingham, MA 01701

    Site contact: Prinicipal Investigator · 508-872-2220 · clinicalresearch@propedix.com

  • Kuchnir Dermatology and Dermatological Surgery

    Milford, MA 01757

    Site contact: Prinicipal Investigator · 508-478-2610 · clinicalresearch@propedix.com

Study contacts (from the official record)

  • Prinicipal Investigator · 617-869-0126 · cschanbacher@propedix.com
All healthy volunteers studies in Massachusetts →
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label… (NCT07245667) | Bored Studies